Ke Chen

6.1k total citations · 1 hit paper
145 papers, 3.4k citations indexed

About

Ke Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ke Chen has authored 145 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 48 papers in Pulmonary and Respiratory Medicine and 38 papers in Surgery. Recurrent topics in Ke Chen's work include Ferroptosis and cancer prognosis (17 papers), Renal cell carcinoma treatment (15 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Ke Chen is often cited by papers focused on Ferroptosis and cancer prognosis (17 papers), Renal cell carcinoma treatment (15 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Ke Chen collaborates with scholars based in China, United States and United Kingdom. Ke Chen's co-authors include Junyi Hu, Lilong Liu, Yaxin Hou, Lijie Zhou, Xiaoping Zhang, Ming Xiong, Hailong Ruan, Zhaohui Chen, Hongmei Yang and Yu Yang and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Ke Chen

137 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma

2020 412 citations Lilong Liu, Yaxin Hou et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ke Chen China	34	1.8k	973	771	766	508	145	3.4k
Chang Zou China	33	2.1k 1.2×	1.1k 1.1×	997 1.3×	547 0.7×	499 1.0×	120	3.9k
Sofia Avnet Italy	36	2.2k 1.2×	1.1k 1.1×	962 1.2×	545 0.7×	254 0.5×	107	3.9k
Dongsheng Huang China	30	2.0k 1.1×	1.2k 1.3×	619 0.8×	260 0.3×	430 0.8×	95	3.2k
Xiaobing Liu China	28	2.2k 1.2×	1.1k 1.1×	869 1.1×	631 0.8×	271 0.5×	150	4.6k
Hua Guo China	38	2.4k 1.3×	1.2k 1.2×	816 1.1×	436 0.6×	366 0.7×	161	4.5k
Weiling He China	31	1.9k 1.0×	1.2k 1.2×	877 1.1×	473 0.6×	557 1.1×	94	3.7k
Tomomi Fujii Japan	30	1.2k 0.7×	437 0.4×	391 0.5×	543 0.7×	177 0.3×	182	2.7k
Yihong Sun China	32	1.3k 0.7×	620 0.6×	1.2k 1.5×	1.2k 1.5×	776 1.5×	142	3.4k
Kohichi Takada Japan	28	1.7k 0.9×	468 0.5×	854 1.1×	469 0.6×	330 0.6×	172	3.7k

Countries citing papers authored by Ke Chen

Since Specialization

Citations

This map shows the geographic impact of Ke Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Chen more than expected).

Fields of papers citing papers by Ke Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Chen. The network helps show where Ke Chen may publish in the future.

Co-authorship network of co-authors of Ke Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Chen. A scholar is included among the top collaborators of Ke Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Chen. Ke Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Ke, et al.. (2025). Association between Prognostic Nutritional Index and myelosuppression in gastric cancer patients undergoing chemotherapy: a retrospective cohort study. Frontiers in Nutrition. 12. 1605421–1605421.

Strowd, Roy E., Macarena de la Fuente, Todd M. Bauer, et al.. (2025). Phase 1 LITESPARK-001 study of belzutifan in participants with advanced solid tumors: results of the glioblastoma expansion cohort. Neuro-Oncology Advances.

Chen, Ke, Ji Young Shin, Haitao Chu, et al.. (2024). Training and dashboard design: Impact on operator performance and mental workload for flight safety. Safety Science. 181. 106700–106700. 2 indexed citations

Liu, Lilong, Zhipeng Yao, Junyi Hu, et al.. (2024). An evaluation of the tumor microenvironment through CALR, IL1R1, IFNB1, and IFNG to assess prognosis and immunotherapy response in bladder cancer patients. eLife. 13.

Song, Zhengshuai, Qi Cao, Bin Guo, et al.. (2023). Overexpression of RACGAP1 by E2F1 Promotes Neuroendocrine Differentiation of Prostate Cancer by Stabilizing EZH2 Expression. Aging and Disease. 14(5). 1757–1757. 22 indexed citations

Chen, Ke, Mingjing Wang, Yumeng Li, et al.. (2023). Activated PRKCD-mediated neutrophil extracellular traps pathway may be the prothrombotic mechanism of neutrophils in polycythemia vera patients based on clinical retrospective analysis and bioinformatics study. International Immunopharmacology. 127. 111366–111366. 1 indexed citations

Hu, Junyi, Kai Ji, Shengpeng Jiang, et al.. (2023). CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells. Cell Reports Medicine. 4(8). 101151–101151. 32 indexed citations

Liu, Qi, Dashan Ai, Ke Chen, et al.. (2023). Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation. Current Treatment Options in Oncology. 24(11). 1568–1579. 7 indexed citations

Luo, Zhiguo, Xin Liu, Xiaoying Zhang, et al.. (2023). 1208MO A randomized phase III trial of site-specific therapy guided by the 90-gene expression assay versus empiric chemotherapy in patients with cancer of unknown primary. Annals of Oncology. 34. S712–S712. 2 indexed citations

10.

Liu, Yuenan, et al.. (2023). Fatty Acid Oxidation Mediated by Malonyl-CoA Decarboxylase Represses Renal Cell Carcinoma Progression. Cancer Research. 83(23). 3920–3939. 25 indexed citations

11.

Liu, Lilong, et al.. (2022). Single cell sequencing reveals that CD39 inhibition mediates changes to the tumor microenvironment. Nature Communications. 13(1). 6740–6740. 41 indexed citations

12.

Ruan, Hailong, Lin Bao, Zhen Tao, & Ke Chen. (2021). Flightless I Homolog Reverses Enzalutamide Resistance through PD-L1–Mediated Immune Evasion in Prostate Cancer. Cancer Immunology Research. 9(7). 838–852. 22 indexed citations

13.

Huang, Yanqin, Nidhi Singh, Jiping Wang, et al.. (2021). Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 65(9). e0069221–e0069221. 17 indexed citations

14.

Chen, Ke, Xuanmao Jiao, Anthony W. Ashton, et al.. (2020). The membrane-associated form of cyclin D1 enhances cellular invasion. Oncogenesis. 9(9). 83–83. 21 indexed citations

15.

Tao, Zhen, Hailong Ruan, Lin Sun, et al.. (2019). Targeting the YB-1/PD-L1 Axis to Enhance Chemotherapy and Antitumor Immunity. Cancer Immunology Research. 7(7). 1135–1147. 61 indexed citations

16.

Cao, Qi, Zhengshuai Song, Hailong Ruan, et al.. (2019). Targeting the KIF4A/AR Axis to Reverse Endocrine Therapy Resistance in Castration-resistant Prostate Cancer. Clinical Cancer Research. 26(6). 1516–1528. 45 indexed citations

17.

Wang, Tao, Wen Song, Yuan Chen, et al.. (2015). Flightless I Homolog Represses Prostate Cancer Progression through Targeting Androgen Receptor Signaling. Clinical Cancer Research. 22(6). 1531–1544. 21 indexed citations

18.

Casimiro, Mathew C., Michael Gormley, Hui Meng, et al.. (2013). Identification of a Cyclin D1 Network in Prostate Cancer That Antagonizes Epithelial–Mesenchymal Restraint. Cancer Research. 74(2). 508–519. 35 indexed citations

19.

Wu, Kongming, Ke Chen, Chenguang Wang, et al.. (2013). Cell Fate Factor DACH1 Represses YB-1–Mediated Oncogenic Transcription and Translation. Cancer Research. 74(3). 829–839. 64 indexed citations

20.

Li, Xiaomei, Xiang-Pei Li, Long Qian, et al.. (2007). [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].. PubMed. 87(15). 1034–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact